The independent platform for news, articles and advice for professionals in laboratory medicine

Tackling antimicrobial resistance: the vital role of diagnostics

In the background of COVID-19, there is another silent pandemic growing – the threat of antimicrobial resistance. In vitro diagnostics are vital in the fight against AMR, ensuring appropriate administration of antibiotics and reducing their misuse.

Antimicrobial resistance (AMR) is creating a future that no science fiction novels had predicted; a future looking more like a distant past, where even minor injuries could lead to life-threatening infections and where modern medicine disappears. While humans are excellent at dealing with urgent situations, sadly we tend to overlook slow threats. Indeed, in the background of COVID-19, a silent pandemic is still growing but few are taking note.

            In 2016, Lord Jim O’Neill made 10 key recommendations to slow down the AMR crisis and qualified diagnostics as the single biggest potential game changer in the fight against AMR. He suggested that, by 2020, all developed economies should make it mandatory to use recognised diagnostic tests before antibiotics can be given1 – in case you were wondering, no country has met this recommendation. His approach was ambitious and highlighted that it is not all about developing new therapeutics, but also preserving the antimicrobials we have available in our arsenal today for future generations.

        There are several reasons why bacteria become resistant to antibiotics, but widespread overuse and incorrect prescribing practices are major culprits. Proper utilisation of diagnostic tests allows the appropriate administration of antibiotics, reducing their misuse and potentially decreasing overall healthcare costs.

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.
Register

Upcoming Events

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025